Similar articles

• Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation.

  Robinson DO, Wills AJ, Hammans SR, Read SP, Sillibourne J. Robinson DO, et al. J Med Genet. 2006 May;43(5):e23. doi: 10.1136/jmg.2005.037598. J Med Genet. 2006. PMID: 16648376 Free PMC article.
• Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene.

  van der Sluijs BM, van Engelen BG, Hoefsloot LH. van der Sluijs BM, et al. Hum Mutat. 2003 May;21(5):553. doi: 10.1002/humu.9138. Hum Mutat. 2003. PMID: 12673802
• Late onset oculopharyngeal muscular dystrophy with prominent neurogenic features and short GCG trinucleotide expansion.

  Piccolo G, Cortese A, Tavazzi E, Piccolo L, Sassone J, Ciammola A, Alfonsi E, Colombo I, Moggio M. Piccolo G, et al. Muscle Nerve. 2011 Jan;43(1):141-2. doi: 10.1002/mus.21842. Muscle Nerve. 2011. PMID: 21171103 No abstract available.
• Oculopharyngeal muscular dystrophy --an under-diagnosed disease in China? Report a China-born Chinese with PABPN1 mutation and epidemiology review of the literature.

  Chien YY. Chien YY. J Formos Med Assoc. 2012 Jul;111(7):397-402. doi: 10.1016/j.jfma.2011.06.017. Epub 2012 May 3. J Formos Med Assoc. 2012. PMID: 22817818 Review.
• Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.

  Davies JE, Berger Z, Rubinsztein DC. Davies JE, et al. Int J Biochem Cell Biol. 2006;38(9):1457-62. doi: 10.1016/j.biocel.2006.01.016. Epub 2006 Feb 28. Int J Biochem Cell Biol. 2006. PMID: 16530457 Review.